USA - NASDAQ:INGN - US45780L1044 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to INGN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-16 | B. Riley Securities | Initiate | Buy |
| 2025-05-22 | Needham | Upgrade | Hold -> Buy |
| 2025-05-08 | Stifel | Maintains | Hold -> Hold |
| 2025-04-09 | Needham | Reiterate | Hold -> Hold |
| 2025-02-27 | Needham | Reiterate | Hold -> Hold |
| 2025-02-26 | Needham | Reiterate | Hold -> Hold |
| 2025-01-30 | Needham | Reiterate | Hold -> Hold |
| 2025-01-14 | Needham | Reiterate | Hold -> Hold |
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-08-07 | Needham | Reiterate | Hold |
| 2024-05-08 | Needham | Reiterate | Hold |
| 2024-05-08 | Stifel | Maintains | Hold -> Hold |
| 2024-04-09 | Needham | Reiterate | Hold |
| 2024-02-15 | William Blair | Upgrade | Market Perform -> Outperform |
| 2023-11-08 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-08-08 | Stifel | Maintains | Hold -> Hold |
| 2023-08-08 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-07-14 | Needham | Downgrade | Buy -> Hold |
| 2023-04-20 | Needham | Reiterate | Buy |
| 2023-02-28 | Needham | Reiterate | Buy |
| 2023-02-24 | Needham | Maintains | Buy |
| 2023-01-17 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-11-03 | JP Morgan | Maintains | Neutral |
| 2022-11-02 | Needham | Maintains | Buy |
| 2022-05-09 | Stifel | Maintains | Hold |
| 2022-05-06 | Needham | Maintains | Buy |
| 2021-12-09 | Needham | Upgrade | Hold -> Buy |
| 2021-11-08 | Stifel | Maintains | Hold |
| 2021-11-05 | SVB Leerink | Maintains | Market Perform |
| 2021-11-02 | JP Morgan | Upgrade | Underweight -> Neutral |
9 analysts have analysed INGN and the average price target is 13.26 USD. This implies a price increase of 57.67% is expected in the next year compared to the current price of 8.41.
The consensus rating for INOGEN INC (INGN) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.